In vivo anticancer study of sodium 2‐[(4‐oxidobenzylidene)amino]‐6H‐1,3,4‐thiadiazine‐5‐olate against Ehrlich ascites carcinoma via targeting PI3K/mTOR pathway
Fuente:
Wiley Open Access
Enregistré dans:
| Auteurs principaux: | Youstina William Rizzk, Ibrahim Mohey El‐Deen, Mohammed El Behery, Ahmed A. E. Mourad, Faten Zahran Mohammed |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2024
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
رؤية مستقبلية أكاديمية للدكتورة دعاء محيي الدين لتطوير التعليم الجامعي من خلال دمج الذكاء الاصطناعي ورقمنه اللغات
par: Mohey El-Din, Doaa
Publié: (2026)
par: Mohey El-Din, Doaa
Publié: (2026)
Ocean Guardians Machine Learning Classifier Based on Sound Whales and Dolphins Supports Sustainable, Eco-Friendly Marine Conservation
par: Mohey El-Din, Doaa
Publié: (2026)
par: Mohey El-Din, Doaa
Publié: (2026)
Ehrlich ascites carcinoma provokes renal toxicity and DNA injury in mice: Therapeutic impact of chitosan and maitake nanoparticles
par: Hamed A. Abosharaf, et autres
Publié: (2024)
par: Hamed A. Abosharaf, et autres
Publié: (2024)
Indoles—A Targeting the PI3K/Akt/mTOR Pathway: Recent Advances in Strategic Design, Mechanism, and Future Perspectives
par: Harish Chandra Vishwakarma, et autres
Publié: (2026)
par: Harish Chandra Vishwakarma, et autres
Publié: (2026)
mTOR Signalling in Arbovirus Infections: Molecular Mechanisms and Therapeutic Opportunities
par: Suad A. Alghamdi, et autres
Publié: (2025)
par: Suad A. Alghamdi, et autres
Publié: (2025)
Exploring new quinazolin‐4(3H)‐one derivatives as CDK2 inhibitors: Design, synthesis, and anticancer evaluation
par: Basant T. Ibrahim, et autres
Publié: (2024)
par: Basant T. Ibrahim, et autres
Publié: (2024)
Synthesis of 1,2,3‐Triazole and Isoxazole Derivatives of [1,2,4]Triazolo[3,4‐b][1,3,4]thiadiazine as Potent EGFR Targeting Antilung Cancer Agents
par: Arvapalli Kiran Kumar, et autres
Publié: (2026)
par: Arvapalli Kiran Kumar, et autres
Publié: (2026)
Melatonin effect on breast and ovarian cancers by targeting the PI3K/Akt/mTOR pathway
par: Vahid Pourbarkhordar, et autres
Publié: (2024)
par: Vahid Pourbarkhordar, et autres
Publié: (2024)
The importance of the PI3K/AKT/mTOR signaling pathway in canine neoplasms: Literature review
par: NP Reis Filho
Publié: (2016)
par: NP Reis Filho
Publié: (2016)
The importance of the PI3K/AKT/mTOR signaling pathway in canine neoplasms: Literature review
par: MGPA Ferreira
Publié: (2016)
par: MGPA Ferreira
Publié: (2016)
B4GALNT1 Regulates Hepatocellular Carcinoma Cell Proliferation and Apoptosis via the PI3K–AKT–mTOR Pathway
par: Lihan Bie, et autres
Publié: (2025)
par: Lihan Bie, et autres
Publié: (2025)
ARF6 Promotes AML Progression via Activation of PI3K / AKT / mTOR Signaling
par: Haitao Xu, et autres
Publié: (2025)
par: Haitao Xu, et autres
Publié: (2025)
Leptin promotes proliferation of human undifferentiated spermatogonia by activating the PI3K/AKT/mTOR pathway
par: Song Xin, et autres
Publié: (2024)
par: Song Xin, et autres
Publié: (2024)
The apoptotic and anti‐proliferative effects of Neosetophomone B in T‐cell acute lymphoblastic leukaemia via PI3K/AKT/mTOR pathway inhibition
par: Shilpa Kuttikrishnan, et autres
Publié: (2024)
par: Shilpa Kuttikrishnan, et autres
Publié: (2024)
An efficient one‐pot, three‐component synthesis of novel [1,2,4]triazolo [4′,3′:1,5][1,2,4]triazolo[3,4‐b][1,3,4]thiadiazine derivatives and their molecular docking studies
par: Parameshwara Chary Jilloju, et autres
Publié: (2024)
par: Parameshwara Chary Jilloju, et autres
Publié: (2024)
IKZF3 Promotes Gastric cancer Progression and Oxaliplatin Resistance via PI3K/AKT/mTOR Activation
par: Chunsheng Tsao, et autres
Publié: (2026)
par: Chunsheng Tsao, et autres
Publié: (2026)
Discovery of Novel 1,3,5‐trisubstituted‐2‐thioxo‐imidazole Derivatives as Potential Aromatase Inhibitors: Design, Synthesis, In Vitro Anti‐Breast Cancer Screening and Molecular Docking Studies
par: Mohamed F. Youssef, et autres
Publié: (2026)
par: Mohamed F. Youssef, et autres
Publié: (2026)
Green‐Synthesized Nanoparticles as Modulators of the PI3K/AKT/mTOR Pathway for Enhancing Ischemic Wound Healing
par: Keren Celestina Mendonce, et autres
Publié: (2026)
par: Keren Celestina Mendonce, et autres
Publié: (2026)
Resveratrol Mitigates the Impairment of Maternal Obesity on Offspring Development by Targeting the PI3K‐AKT‐mTOR Pathways
par: Xizi Yang, et autres
Publié: (2026)
par: Xizi Yang, et autres
Publié: (2026)
Microneedle‐Delivered PDA@Exo for Multifaceted Osteoarthritis Treatment via PI3K‐Akt‐mTOR Pathway
par: Zihua Li, et autres
Publié: (2024)
par: Zihua Li, et autres
Publié: (2024)
The PI3K/AKT/mTOR Pathway and Oral Diseases: A Bibliometric Analysis From 2008 to 2025
par: Yena Gan, et autres
Publié: (2025)
par: Yena Gan, et autres
Publié: (2025)
Kdf1 Regulates Molar Cusp Morphogenesis via the PI3K / AKT / mTOR Signalling Axis
par: Jiayu Wang, et autres
Publié: (2025)
par: Jiayu Wang, et autres
Publié: (2025)
Targeting the PI3K/pAKT/mTOR/NF‐κB/FOXO3a signaling pathway for suppressing the development of hepatocellular carcinoma in rats: Role of the natural remedic Suaeda vermiculata forssk
par: Mohamed S. Abdel‐Bakky, et autres
Publié: (2024)
par: Mohamed S. Abdel‐Bakky, et autres
Publié: (2024)
Rewiring mTOR signaling in Alzheimer's disease: emerging mTOR modulators beyond oncology.
par: Lohnes, Benedikt Jakob, et autres
Publié: (2026)
par: Lohnes, Benedikt Jakob, et autres
Publié: (2026)
Inhibitors of the mTOR signaling pathway can play an important role in breast cancer immunopathogenesis
par: Sulieman I. Shelash Al‐Hawary, et autres
Publié: (2024)
par: Sulieman I. Shelash Al‐Hawary, et autres
Publié: (2024)
Xinlikang Capsule Alleviates Chemotherapy‐Induced Fatigue by Inhibiting the PI3K/AKT‐mTOR‐FoxO Pathway
par: Suzhou Huang, et autres
Publié: (2026)
par: Suzhou Huang, et autres
Publié: (2026)
Computational Analysis of Azole Derivatives Targeting the PI3K/AKT/mTOR Pathway With In Vitro Cytotoxicity and Autophagy Evaluation.
par: Regurajan, Rathika, et autres
Publié: (2026)
par: Regurajan, Rathika, et autres
Publié: (2026)
The Effect of FPR2 on the Regulation of Trophoblast Autophagy via the PI3K/AKT/mTOR Signaling Pathway in Preeclampsia
par: Ning Jiang, et autres
Publié: (2025)
par: Ning Jiang, et autres
Publié: (2025)
RETRACTION: Chelerythrine Inhibits Stemness of Cancer Stem‐Like Cells of Osteosarcoma and PI3K/AKT/mTOR Signal
par: Journal of Oncology
Publié: (2025)
par: Journal of Oncology
Publié: (2025)
Expert Consensus on the Clinical Application of PI3K/AKT/mTOR Inhibitors in the Treatment of Breast Cancer (2025 Edition)
Publié: (2025)
Publié: (2025)
Targeted Therapies in Infantile Hemangiomas and Vascular Malformations: From β‐Blockers to PI3K / AKT / mTOR Inhibitors
par: Hubert Arasiewicz, et autres
Publié: (2026)
par: Hubert Arasiewicz, et autres
Publié: (2026)
SERPINB6 Promotes Epithelial‐Mesenchymal Transition via PI3K/AKT/mTOR Signalling Pathway in Glioma
par: Ding Wang, et autres
Publié: (2025)
par: Ding Wang, et autres
Publié: (2025)
Mechanistic Insights Into the Hepatoprotective Effects of Punicalagin Against Oxidative Stress: Involvement of the PI3K/AKT/mTOR Pathway and Autophagy
par: Xia Yang, et autres
Publié: (2026)
par: Xia Yang, et autres
Publié: (2026)
Neuritin accelerates Schwann cell dedifferentiation via PI3K/Akt/mTOR signalling pathway during Wallerian degeneration
par: Jingmin Liu, et autres
Publié: (2024)
par: Jingmin Liu, et autres
Publié: (2024)
Transferrin Receptor Promotes Endometrial Cancer Proliferation by Activating the Iron‐Dependent PI3K/AKT/mTOR Signaling Pathway
par: Yufei Yang, et autres
Publié: (2025)
par: Yufei Yang, et autres
Publié: (2025)
Liraglutide Ameliorates Injury‐Related Vascular Repair by Activating Autophagy Through Modulation of the PI3K–mTOR Signaling Pathway
par: Zongyi Zhang, et autres
Publié: (2026)
par: Zongyi Zhang, et autres
Publié: (2026)
High glucose inhibits autophagy and promotes the proliferation and metastasis of colorectal cancer through the PI3K/AKT/mTOR pathway
par: Feng Li, et autres
Publié: (2024)
par: Feng Li, et autres
Publié: (2024)
Phillygenin Inhibits PI3K‐Akt–mTOR Signalling Pathway to Prevent bleomycin‐Induced Idiopathic Pulmonary Fibrosis in Mice
par: Yongjia Wei, et autres
Publié: (2025)
par: Yongjia Wei, et autres
Publié: (2025)
Downregulation of aquaporin 3 promotes hyperosmolarity-induced apoptosis of nucleus pulposus cells through PI3K/Akt/mTOR pathway suppression
par: Sang, Yuan, et autres
Publié: (2025)
par: Sang, Yuan, et autres
Publié: (2025)
Isoalantolactone exerts anti‐melanoma effects via inhibiting PI3K/AKT/mTOR and STAT3 signaling in cell and mouse models
par: Jun‐Kui Li, et autres
Publié: (2024)
par: Jun‐Kui Li, et autres
Publié: (2024)
Documents similaires
-
رؤية مستقبلية أكاديمية للدكتورة دعاء محيي الدين لتطوير التعليم الجامعي من خلال دمج الذكاء الاصطناعي ورقمنه اللغات
par: Mohey El-Din, Doaa
Publié: (2026) -
Ocean Guardians Machine Learning Classifier Based on Sound Whales and Dolphins Supports Sustainable, Eco-Friendly Marine Conservation
par: Mohey El-Din, Doaa
Publié: (2026) -
Ehrlich ascites carcinoma provokes renal toxicity and DNA injury in mice: Therapeutic impact of chitosan and maitake nanoparticles
par: Hamed A. Abosharaf, et autres
Publié: (2024) -
Indoles—A Targeting the PI3K/Akt/mTOR Pathway: Recent Advances in Strategic Design, Mechanism, and Future Perspectives
par: Harish Chandra Vishwakarma, et autres
Publié: (2026) -
mTOR Signalling in Arbovirus Infections: Molecular Mechanisms and Therapeutic Opportunities
par: Suad A. Alghamdi, et autres
Publié: (2025)